Regularly monitor neuropsychiatric symptoms in Parkinson’s disease and adjust treatment as necessary
- 9 Downloads
Neuropsychiatric disorders are frequent in Parkinson’s disease (PD), but may be difficult to identify as they are closely related to other aspects of PD, such as motor impairment and non-motor fluctuations. While integral to PD treatment, dopaminergic therapies may contribute significantly to neuropsychiatric symptoms. Treatments in PD should be constantly reviewed and balanced, such as by adjusting doses appropriately, to minimize neuropsychiatric issues among other adverse events.
Compliance with ethical standards
Conflict of interest
The article was adapted from CNS Drugs 2018;32(7):621–35  by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.
The preparation of this review was not supported by any external funding.
- 8.Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci. 2005;28(6):737–57.Google Scholar
- 17.Parkinson’s disease in adults. NICE guideline 71. London: National Institute for Health and Care Excellence; 2017.Google Scholar
- 25.Deuschl G, Fogel W, Hahne M, et al. Deep-brain stimulation for Parkinson’s disease. J Neurol. 2002;249(Suppl 3):III/36–9.Google Scholar
- 29.Oguro H, Nakagawa T, Mitaki S, et al. Randomized trial of repetitive transcranial magnetic stimulation for apathy and depression in Parkinson’s disease. J Neurol Neurophysiol. 2014;5(5):242.Google Scholar